Home / Street Sector / Active Broker’s Choice in Focus: Air Products and Chemicals (NYSE:APD), Acasti Pharma (NASDAQ:ACST)

Active Broker’s Choice in Focus: Air Products and Chemicals (NYSE:APD), Acasti Pharma (NASDAQ:ACST)

Air Products and Chemicals, Inc. (NYSE:APD) [Trend Analysis] surged reacts as active mover, shares an raise 0.17% to traded at $141.78 and the percentage gap among open changing to regular change was -0.08%. Air Products (APD) and Grupa Azoty Zakłady Azotowe Kędzierzyn S.A., have inked a long-term contract for the delivery of oxygen and nitrogen. The contract will remain valid until the end of 2035 and extends cooperation among the companies which dates back to 1997. The contract also secures Air Products’ position as a key supplier to major industries in Poland.

Under the contract, Air Products will provide oxygen and nitrogen gas to the Grupa Azoty Zakłady Azotowe Kędzierzyn plant, as well as liquid oxygen and nitrogen to other consumers in Poland. The project will be implemented on the basis of an upgrade of Air Products’ production facility which, with a capacity of about 2,000 tons per day, is one of the largest of its kind in Poland. Industrial gases supplied by Air Products are used by Grupa Azoty Zakłady Azotowe Kędzierzyn S.A. for the production of ammonia, OXO alcohols and in auxiliary processes. Nitrogen is also used to ensure the safety of production facilities on-site. The firm’s current ratio calculated as 1.30 for the most recent quarter. The firm past twelve months price to sales ratio was 3.24 and price to cash ratio remained 20.53. As far as the returns are concern, the return on equity was recorded as 8.90% and return on investment was 11.40% while its return on asset stayed at 3.60%. The firm has total debt to equity ratio measured as 0.88.

Acasti Pharma Inc. (NASDAQ:ACST) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 11.07% to $1.38. Acasti Pharma Inc. (NASDAQ:ACST) reported that Linda O’Keefe has been designatedchief financial officer. Ms. O’Keefe brings to Acasti over 30 years of financial experience in the life sciences, manufacturing and business service sectors. As part of the firm’s strategy to operate independently of parent firm Neptune Technologies & Bioressources Inc., Mario Paradis has reinked as chief financial officer from Acasti to focus solely on his role as vice president and chief financial officer of Neptune.

“We appreciate Mario’s commitment to Acasti and wish him all the best as he dedicates his time to serving as Neptune’s chief financial officer,” stated Jan D’Alvise, president and CEO of Acasti. “Linda joins us as an completed individual with important financial experience in the life sciences industry, and a proven track record of overseeing finance and accounting and building value at emerging biotech companies. Linda will be an asset to Acasti as we execute our drug development and commercialization strategy for CaPre® with financial discipline and compliance.” The share price of ACST attracts active investors, as stock price of week volatility recorded 8.30%. The stock is going forward to its 52-week low with 14.77% and lagging behind from its 52-week high price with -56.96%.


About Richard Avery

He is a capital projects manager and process design engineer at a large-cap company. He has renowned MBA degree. Before joining SWR, he was a freelance writer for renounce tech websites. He is currently studying for CFP exam. Interests: Tech stocks, Economic Markets, Blue-chips.

Check Also

Stocks Luring Investors with Juicy Profitability Figures: Oclaro, Inc. (NASDAQ:OCLR), Teradata Corporation (NYSE:TDC)

Oclaro, Inc. (NASDAQ:OCLR) persists its position slightly strong in context of buying side, while shares …

Leave a Reply

Your email address will not be published. Required fields are marked *